P.A.W. CAPITAL CORP - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 92 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
P.A.W. CAPITAL CORP ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$838,000
+5.0%
250,000
-16.7%
0.83%
-17.2%
Q4 2018$798,000
-43.0%
300,000
+20.0%
1.00%
-32.6%
Q3 2018$1,400,000250,0001.49%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 9,775,849$2,913,2031.93%
Aquilo Capital Management, LLC 3,303,190$984,3510.89%
CM Management, LLC 649,400$193,5210.20%
BVF INC/IL 20,609,863$6,141,7390.17%
WEALTH EFFECTS LLC 11,700$3,4870.00%
NJ State Employees Deferred Compensation Plan 30,000$8,9400.00%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 14,000$4,1720.00%
ACADIAN ASSET MANAGEMENT LLC 962,358$2860.00%
TWO SIGMA ADVISERS, LP 24,400$7,2710.00%
Tower View Wealth Management LLC 1,000$00.00%
View complete list of PIERIS PHARMACEUTICALS INC shareholders